Across TCGA pan-cancer cohorts, DLEC1P1 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of DLEC1P1’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where DLEC1P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types DLEC1P1 is over-expressed in tumor.
KIRP and KIRC are the cancer types where DLEC1P1 tumor–normal differential expression is most reproducible.